Genzyme

William M. Canfield, M.D., Ph.D.
President
800 Research Parkway
Suite 200
Oklahoma City, OK 73104
Phone: 405/271-8144
FAX: 405/271-8144
www.genzyme.com


Since its founding in 1981, Genzyme has dedicated itself to discovering and developing innovative products and services to improve the lives of patients with debilitating diseases. This commitment has driven Genzyme to establish many new models in treatment and testing, and has brought hope to thousands of people affected by devastating and, in many cases, previously untreatable illnesses.

Over the years, Genzyme-sponsored research and development has led to the introduction of new treatments for many serious health problems including rare and debilitating genetic diseases, renal disease, and orthopaedic injuries.

From state-of-the-art technologies to innovative therapies
Genzyme's international team of over 400 scientists is continually working to identify new opportunities to meet the health care challenges of the future. Genzyme is committed to investing in their work, and in 2001, dedicated approximately $188 million - or 19 percent of total revenues - to internal research and development.

Building on over twenty years of leadership in biomedical research, Genzyme is leveraging the power of today's innovative technologies to refine its expertise in a broad range of scientific platforms. The company's areas of expertise include surgical biomaterials, cell and protein therapeutics, diagnostic products and services, small molecule/drug discovery, genetics and genomics and therapeutic polymers.

In addition to the research taking place in Genzyme's own laboratories, the company also supports vital research conducted by leading academic and independent medical science centers, and works collaboratively with its development partners to bring innovative therapies to market.

Across the organization, Genzyme is committed to creating, recognizing, and acting on scientific breakthroughs to develop the next generation of life-saving and life-enhancing medical products.